WHO chief says impact of newly approved COVID drugs depends on 2 factors. Read here
- WHO recommended two new drugs to treat COVID patients - Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody
On World Health Organization (WHO) recommending the use of two new drugs for treatment of Covid-19 patients, WHO chief Tedros Adhanom Ghebreyesus notified that their success and impact will depend on how widely available and affordable they will be. This comes as Omicron cases fill hospitals around the world.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more